Trials / Unknown
UnknownNCT02204878
Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy
A Randomized, Phase IV Study Exploring the Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To searching the role of parecoxib sodium for postoperative pain management in open hepatectomy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Parecoxib Sodium | Dynastat 40mg was given before anesthesia. PCA will be attached right before closing abdomen. Concentration of sufentanil is 1ug/ml. PCA settings: 1) no background infusion; 2) bolus 2ml sufentanil each; 3) with the lockout time 5 min, 1 hour limit: 10ml. Dynastat 40mg Q12h will be given within 72 hours after surgery |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-08-01
- First posted
- 2014-07-30
- Last updated
- 2014-07-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02204878. Inclusion in this directory is not an endorsement.